Quotient Ltd

NASDAQ:QTNT  
0.24
0.00 (+0.04%)
Products, Strategic Combinations, Expansion

Theradiag, Quotient Ltd Partner On Autoimmune Disease Diagnostics

Published: 06/08/2022 09:19 GMT
Quotient Ltd (QTNT) - Quotient Limited and Theradiag Announce Partnership to Advance Autoimmune Disease Diagnostics.
Expands Access to $2 Billion Autoimmune Ivd Specialty Market With Mosaiq.
Targeted Market Introduction in Later Half of Cy2023.
Under New Agreement, Theradiag Will Supply Quotient With Autoimmune Reagents and Multi-constituent Quality Controls, for Development of Autoimmune Microarrays to Be Used on Mosaiq Solution.
Parties Intend First Application Covered by Their New Collaboration Will Be a Solution for Connective Tissue Diseases (ctd).